Novartis AG said profit may fall this year as the Swiss drugmaker increases spending on the heart medicine Entresto and faces declining sales of its best-selling cancer treatment Gleevec.
See Original Article
Turkish President Recep Tayyip Erdogan's sweeping crackdown on opponents may leave him exposed in the face of other mounting threats.
See Original Article
South Korea accused North Korea of a “reckless provocation” Tuesday after the country test-fired three ballistic missiles, the latest in a series of
See Original Article
Searing temperatures caused by climate change may cost global economies more than $2 trillion by 2030, restricting working hours in some of the
See Original Article
The dreaded spreadsheet: It's often cited by FinTech players as one of the most cumbersome and least efficient manual accounting tools.
See Original Article

Leave a Reply